{
    "Trade/Device Name(s)": [
        "ACE Cholesterol Reagent",
        "ACE HDL-C Reagent",
        "ACE LDL-C Reagent",
        "ACE Triglycerides Reagent"
    ],
    "Submitter Information": "Alfa Wassermann Diagnostic Technologies, LLC",
    "510(k) Number": "K112538",
    "Predicate Device Reference 510(k) Number(s)": [
        "K931786",
        "K971526",
        "K991733"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "CHH",
        "LBS",
        "MRR",
        "CDT"
    ],
    "Summary Letter Date": "March 19, 2012",
    "Summary Letter Received Date": "March 20, 2012",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR862.1175",
        "21CFR862.1475",
        "21CFR862.1705"
    ],
    "Regulation Name(s)": [
        "Cholesterol Test Reagent",
        "LDL & VLDL Precipitation",
        "Enzyme, Triglycerides"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Cholesterol",
        "HDL Cholesterol",
        "LDL Cholesterol",
        "Triglycerides"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Lithium heparin plasma"
    ],
    "Specimen Container(s)": [
        "Serum tube",
        "Lithium heparin tube"
    ],
    "Instrument(s)/Platform(s)": [
        "ACE Clinical Chemistry System",
        "ACE Alera Clinical Chemistry System"
    ],
    "Method(s)/Technology(ies)": [
        "Enzymatic Esterase-Oxidase",
        "Detergent-based homogenous assay",
        "Lipase Hydrolysis/Glycerol Kinase"
    ],
    "Methodologies": [
        "Colorimetric determination",
        "Bichromatic absorbance measurement"
    ],
    "Submission Type(s)": [
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for ACE Cholesterol, HDL-C, LDL-C, and Triglycerides Reagents for quantitative measurement on ACE and ACE Alera systems",
    "Indications for Use Summary": "For the quantitative determination of cholesterol, HDL cholesterol, LDL cholesterol, and triglycerides in serum and lithium heparin plasma using ACE and ACE Alera Clinical Chemistry Systems, aiding diagnosis and treatment of lipid metabolism disorders in clinical or physician office laboratories",
    "fda_folder": "Clinical Chemistry"
}